NCT03826459

Brief Summary

Cesarean section accounts for nearly 30% of births in Canada, and is the most commonly performed surgery by Obstetrician Gynecologists. Cesarean scar isthmocele, meaning a defect in the uterine wall at the site of a previous uterine incision, is a common complication of this surgery. While most are likely asymptomatic, isthmoceles can lead to major complications in pregnancy (uterine rupture, invasive placentation, cesarean scar ectopic pregnancy) and outside of pregnancy (abnormal uterine bleeding, infertility and pain). Studies have shown that the method used to suture the uterus at the time of a cesarean section may have an impact on the incidence of post-operative isthmocele formation. Our study is a randomized control trial of the impact of locked vs unlocked uterine closure at cesarean section on the incidence of isthmocele formation. Women undergoing cesarean section will be randomized to have either a locked or unlocked uterine closure. They will then return 6 months after their surgery for a transvaginal ultrasound to evaluate the presence or absence of an isthmocele. This study is a pilot trial. The investigators hope to determine the feasibility of completing a large randomized control trial by recording: a) the number of patient who agree to participate in this study, b) the number of patients who receive the correct intervention and, c) the number of patients who return for their post operative ultrasound. The investigators also plan to assess multiple secondary outcomes. First, the goal is to determine the isthmocele incidence within the study subjects of the pilot trial in order to perform a power calculation for a subsequent larger trial in this area. Another goal is to determine if the uterine closure techniques in this study lead to differences in surgical time, blood loss or the need for intra- or post-operative blood transfusion. Last, the study will collect data on the suture material most commonly used in this study to determine if this requires standardization in the subsequent larger trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 28, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 1, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

March 5, 2019

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 18, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 18, 2020

Completed
Last Updated

January 25, 2022

Status Verified

January 1, 2022

Enrollment Period

1.8 years

First QC Date

January 28, 2019

Last Update Submit

January 22, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Number of Participants Enrolled

    Number of potential participants approached who actually enrolled in the trial

    6 months

  • Number of Participants that Cross-Over

    Number of participants who cross-over to the other study arm (i.e. who receive the incorrect uterine closure technique)

    6 months

  • Number of Participants Lost to Follow Up

    Number of participants enrolled in the trial who do not present for their follow up ultrasound at 6 months.

    6 months

Secondary Outcomes (11)

  • Incidence of Isthmocele

    6 months

  • Estimated Blood Loss

    Through surgery completion (estimated 1 hour)

  • Change in Hemoglobin

    24 hours

  • Operative Time

    Through surgery completion (estimated 1 hour)

  • Number of Blood Transfusions

    Throughout hospital stay (estimated 48 hours)

  • +6 more secondary outcomes

Study Arms (2)

Locked Uterine Closure

ACTIVE COMPARATOR

Participants will undergo two-layer closure of the hysterotomy site at the time of cesarean section. The first layer will use a running \& locking technique. The second layer will be performed based on surgeon preference.

Procedure: Locked Uterine Closure

Non-Locking Uterine Closure

EXPERIMENTAL

Participants will undergo two-layer closure of the hysterotomy site at the time of cesarean section. The first layer will use a running \& non-locking technique. The second layer will be performed based on surgeon preference, but cannot be of a locking technique.

Procedure: Non-Locking Uterine Closure

Interventions

The first layer of the two-layer uterine closure will be sutured with a running \& non-locking technique. The second layer cannot be of a locking technique.

Non-Locking Uterine Closure

The first layer of the two-layer uterine closure will be sutured with a running \& locking technique. The second layer can be locking or non-locking.

Locked Uterine Closure

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsSince this is a study done at the time of cesarean section, only females are eligible.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women undergoing their first cesarean section

You may not qualify if:

  • previous uterine hysterotomy (caesarean section, myomectomy, etc.)
  • known uterine anomalies
  • active labour
  • known bleeding disorder
  • maternal connective tissue disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mount Sinai Hospital

Toronto, Ontario, M5G1Z5, Canada

Location

Related Publications (1)

  • Warshafsky C, Kirubarajan A, Chaikof M, Stere A, Chudawala U, Li Q, Huszti E, Mohamed D, Abdalla MH, Hartman A, Sanders A, Murji A, Sobel M. Preventing Isthmocele After Cesarean Section (PICS): A Pilot Randomized Controlled Trial. J Obstet Gynaecol Can. 2022 Nov;44(11):1134-1135. doi: 10.1016/j.jogc.2022.08.003. Epub 2022 Aug 12. No abstract available.

Study Officials

  • Mara Sobel, MD

    MOUNT SINAI HOSPITAL

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Participants will be randomized to either locked or non-locked uterine closure at the time of cesarean section.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Obstetrician/Gynecologist

Study Record Dates

First Submitted

January 28, 2019

First Posted

February 1, 2019

Study Start

March 5, 2019

Primary Completion

December 18, 2020

Study Completion

December 18, 2020

Last Updated

January 25, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations